Comparing biological information contained in mRNA and non-coding RNAs for classification of lung cancer patients.

Abstract:

BACKGROUND:Deciphering the meaning of the human DNA is an outstanding goal which would revolutionize medicine and our way for treating diseases. In recent years, non-coding RNAs have attracted much attention and shown to be functional in part. Yet the importance of these RNAs especially for higher biological functions remains under investigation. METHODS:In this paper, we analyze RNA-seq data, including non-coding and protein coding RNAs, from lung adenocarcinoma patients, a histologic subtype of non-small-cell lung cancer, with deep learning neural networks and other state-of-the-art classification methods. The purpose of our paper is three-fold. First, we compare the classification performance of different versions of deep belief networks with SVMs, decision trees and random forests. Second, we compare the classification capabilities of protein coding and non-coding RNAs. Third, we study the influence of feature selection on the classification performance. RESULTS:As a result, we find that deep belief networks perform at least competitively to other state-of-the-art classifiers. Second, data from non-coding RNAs perform better than coding RNAs across a number of different classification methods. This demonstrates the equivalence of predictive information as captured by non-coding RNAs compared to protein coding RNAs, conventionally used in computational diagnostics tasks. Third, we find that feature selection has in general a negative effect on the classification performance which means that unfiltered data with all features give the best classification results. CONCLUSIONS:Our study is the first to use ncRNAs beyond miRNAs for the computational classification of cancer and for performing a direct comparison of the classification capabilities of protein coding RNAs and non-coding RNAs.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Smolander J,Stupnikov A,Glazko G,Dehmer M,Emmert-Streib F

doi

10.1186/s12885-019-6338-1

subject

Has Abstract

pub_date

2019-12-03 00:00:00

pages

1176

issue

1

issn

1471-2407

pii

10.1186/s12885-019-6338-1

journal_volume

19

pub_type

杂志文章
  • CXCR4-SDF-1 interaction potentially mediates trafficking of circulating tumor cells in primary breast cancer.

    abstract:BACKGROUND:Cytokines are involved in cancer invasion and metastasis. Circulating tumor cells (CTCs) play key role in tumor dissemination and are an independent survival predictor in breast cancer patients. The aim of this study was to assess correlation between CTCs and plasma cytokines in primary breast cancer (PBC) p...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2143-2

    authors: Mego M,Cholujova D,Minarik G,Sedlackova T,Gronesova P,Karaba M,Benca J,Cingelova S,Cierna Z,Manasova D,Pindak D,Sufliarsky J,Cristofanilli M,Reuben JM,Mardiak J

    更新日期:2016-02-19 00:00:00

  • Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma.

    abstract:BACKGROUND:The development and evaluation of new therapeutic approaches for malignant mesothelioma has been sparse due, in part, to lack of suitable tumor models. METHODS:We established primary mesothelioma cultures from pleural and ascitic fluids of five patients with advanced mesothelioma. Electron microscopy and im...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1362-2

    authors: Kalra N,Zhang J,Thomas A,Xi L,Cheung M,Talarchek J,Burkett S,Tsokos MG,Chen Y,Raffeld M,Miettinen M,Pastan I,Testa JR,Hassan R

    更新日期:2015-05-08 00:00:00

  • Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.

    abstract:BACKGROUND:HER2/neu overexpression is linked to promotion of angiogenesis in breast cancer. We therefore tested the activity of the combination of Trastuzumab with metronomic, low dose chemotherapy with cyclophosphamide (CTX) and methotrexate (MTX) in metastatic breast cancer (MBC). METHODS:Between April 2002 and June...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章

    doi:10.1186/1471-2407-6-225

    authors: Orlando L,Cardillo A,Ghisini R,Rocca A,Balduzzi A,Torrisi R,Peruzzotti G,Goldhirsch A,Pietri E,Colleoni M

    更新日期:2006-09-15 00:00:00

  • CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.

    abstract:BACKGROUND:CD73 has both enzymatic and non-enzymatic functions in cells. As a nucleotidase, CD73 plays its enzymatic function by catalyzing the hydrolysis of AMP into adenosine and phosphate. In addition to this, accumulating data have shown that CD73 is a key regulatory molecule involved in cancer growth and metastasi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3128-5

    authors: Gao ZW,Wang HP,Lin F,Wang X,Long M,Zhang HZ,Dong K

    更新日期:2017-02-15 00:00:00

  • Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies.

    abstract:BACKGROUND:The role of radiation therapy in addition to chemotherapy has not been well established in non-oligometastatic Stage IV non-small cell lung cancer (NSCLC). We aimed to investigate overall survival (OS) of non-oligometastatic Stage IV NSCLC treated with chemotherapy with concurrent radiation to the primary tu...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2952-3

    authors: Su S,Hu Y,Ouyang W,Ma Z,Li Q,Li H,Wang Y,Wang X,Li T,Li J,Chen M,Lu Y,Bai Y,He Z,Lu B

    更新日期:2016-11-21 00:00:00

  • Centralising specialist cancer surgery services in England: survey of factors that matter to patients and carers and health professionals.

    abstract:BACKGROUND:The centralisation of specialist cancer surgical services across London Cancer and Greater Manchester Cancer, England, may significantly change how patients experience care. These centres are changing specialist surgical pathways for several cancers including prostate, bladder, kidney, and oesophago-gastric ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4137-8

    authors: Melnychuk M,Vindrola-Padros C,Aitchison M,Clarke CS,Fulop NJ,Levermore C,Maddineni SB,Moore CM,Mughal MM,Perry C,Pritchard-Jones K,Ramsay AIG,Shackley D,Vickers J,Morris S

    更新日期:2018-02-27 00:00:00

  • Diffuse large B cell lymphoma derived from nodular lymphocyte predominant Hodgkin lymphoma presents with variable histopathology.

    abstract:BACKGROUND:Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) usually presents in middle aged men and shows an indolent clinical behavior. However, up to 30% of the patients present a secondary transformation into aggressive diffuse large B cell lymphoma (DLBCL). The aim of the present study was to characterize mo...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-332

    authors: Hartmann S,Eray M,Döring C,Lehtinen T,Brunnberg U,Kujala P,Vornanen M,Hansmann ML

    更新日期:2014-05-13 00:00:00

  • A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen.

    abstract:BACKGROUND:Colorectal cancer is a major public health issue worldwide. Interleukin-17 (IL-17) and Th17 (T-helper cell type 17)-related molecules are involved in tumor development and in resistance to bevacizumab, an anti-vascular endothelial growth factor monoclonal antibody used in association with chemotherapy in met...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3210-z

    authors: Lereclus E,Tout M,Girault A,Baroukh N,Caulet M,Borg C,Bouché O,Ternant D,Paintaud G,Lecomte T,Raoul W

    更新日期:2017-03-27 00:00:00

  • Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report.

    abstract:BACKGROUND:Pseudomyogenic hemangioendothelioma (PMHE) is a rare endothelial neoplasm that involves the bones in only 14% of all cases. The optimal treatment strategy has not been established. We herein report a case of primary PMHE in which denosumab treatment showed activity in both imaging studies and the clinical ou...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6072-8

    authors: Otani S,Nakayama R,Sekita T,Hirozane T,Asano N,Nishimoto K,Sasaki A,Okita H,Morioka H,Nakamura M,Matsumoto M

    更新日期:2019-09-03 00:00:00

  • Diagnostic values of serum cathepsin B and D in patients with nasopharyngeal carcinoma.

    abstract:BACKGROUND:The diagnostic and prognostic significance of increased cathepsin B (CTSB) and cathepsin D (CTSD) concentration in the serum of cancer patients were evaluated for some tumor types. High expression of CTSD and CTSB was detected in biopsy tissues from nasopharyngeal carcinoma (NPC). However, whether CTSD and C...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2283-4

    authors: Tan G,Liu Q,Tang X,Kang T,Li Y,Lu J,Zhao X,Tang F

    更新日期:2016-03-19 00:00:00

  • Results of concurrent radio-chemotherapy for the treatment of head and neck squamous cell carcinoma in everyday clinical practice with special reference to early mortality.

    abstract:BACKGROUND:Randomized controlled trials have established concurrent chemo-radiotherapy as the preferred treatment option for inoperable local-regionally advanced head and neck squamous cell carcinomas (HNSCCs). Because many patients have multiple co-morbidities and would not fulfill the eligibility criteria of clinical...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-610

    authors: Schlumpf M,Fischer C,Naehrig D,Rochlitz C,Buess M

    更新日期:2013-12-27 00:00:00

  • Does D3 surgery offer a better survival outcome compared to D1 surgery for gastric cancer? A result based on a hospital population of two decades as taking D2 surgery for reference.

    abstract:BACKGROUND:We conducted a retrospective study in our hospital in which we compared D1 with D3 through D2 lymphadenectomy for gastric cancer in terms of morbidity, postoperative mortality, long-term survival after surgery. METHODS:567 patients who were performed curative intent between 1980 and 2003 were enrolled. 187 ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-308

    authors: Zhang H,Liu C,Wu D,Meng Y,Song R,Lu P,Wang S

    更新日期:2010-06-20 00:00:00

  • Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells.

    abstract:BACKGROUND:Cancer stem cell (CSC) hypothesis has not been well demonstrated by the lack of the most convincing evidence concerning a single cell capable of giving rise to a tumor. The scarcity in quantity and improper approaches for isolation and purification of CSCs have become the major obstacles for great developmen...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-135

    authors: Li HZ,Yi TB,Wu ZY

    更新日期:2008-05-14 00:00:00

  • The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.

    abstract:BACKGROUND:C3H mice have been frequently used in cancer studies as animal models of spontaneous liver tumors and chemically induced hepatocellular carcinoma (HCC). Epigenetic modifications, including DNA methylation, are among pivotal control mechanisms of gene expression leading to carcinogenesis. Although information...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4221-0

    authors: Matsushita J,Okamura K,Nakabayashi K,Suzuki T,Horibe Y,Kawai T,Sakurai T,Yamashita S,Higami Y,Ichihara G,Hata K,Nohara K

    更新日期:2018-03-22 00:00:00

  • Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".

    abstract:BACKGROUND:The purpose of this study was to evaluate socio-demographic characteristics of clients claiming genetic counseling for hereditary breast and ovarian cancer (HBOC) in Austria. Furthermore, changes of these parameters before and after Angelina Jolie's (AJ) disclosure of carrying a BRCA mutation were evaluated....

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2472-1

    authors: Staudigl C,Pfeiler G,Hrauda K,Renz R,Berger A,Lichtenschopf R,Singer CF,Tea MK

    更新日期:2016-07-08 00:00:00

  • The effects of shared decision-making compared to usual care for prostate cancer screening decisions: a systematic review and meta-analysis.

    abstract:BACKGROUND:Shared decision-making (SDM) is recommended for men facing prostate cancer (PC) screening decisions. We synthesize the evidence on the comparative effectiveness of SDM with usual care. METHODS:We searched academic and grey literature databases, and other sources for primary randomised controlled trials (RCT...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4794-7

    authors: Martínez-González NA,Neuner-Jehle S,Plate A,Rosemann T,Senn O

    更新日期:2018-10-22 00:00:00

  • Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.

    abstract:BACKGROUND:The epithelial-mesenchymal transition (EMT) plays a pivotal role in various physiological processes, such as embryonic development, tissue morphogenesis, and wound healing. EMT also plays an important role in cancer invasion, metastasis, and chemoresistance. Additionally, EMT is partially responsible for che...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07615-5

    authors: Zhang Z,Zheng S,Lin Y,Sun J,Ding N,Chen J,Zhong J,Shi L,Xue M

    更新日期:2020-11-23 00:00:00

  • Return to work in sick-listed cancer survivors with job loss: design of a randomised controlled trial.

    abstract:BACKGROUND:Despite long-term or permanent health problems, cancer survivors are often motivated to return to work. For cancer survivors who have lost their job, return to work can be more challenging compared to employed survivors, as they generally find themselves in a more vulnerable social and financial position. Ca...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12885-015-1051-1

    authors: van Egmond MP,Duijts SF,Vermeulen SJ,van der Beek AJ,Anema JR

    更新日期:2015-02-18 00:00:00

  • Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis.

    abstract:BACKGROUND:Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provide an effective treatment option for selected patients with colorectal peritoneal metastasis with encouraging survival results. Many different drug combinations and HIPEC regimens including bidirectional, i.e. synchronous ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-807

    authors: Glockzin G,Gerken M,Lang SA,Klinkhammer-Schalke M,Piso P,Schlitt HJ

    更新日期:2014-11-04 00:00:00

  • Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancer.

    abstract:BACKGROUND:The principle of loss of iodine uptake and increased glucose metabolism according to dedifferentiation of thyroid cancer is clinically assessed by imaging. Though these biological properties are widely applied to appropriate iodine therapy, the understanding of the genomic background of this principle is sti...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6482-7

    authors: Suh HY,Choi H,Paeng JC,Cheon GJ,Chung JK,Kang KW

    更新日期:2019-12-30 00:00:00

  • Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling.

    abstract:BACKGROUND:The differentiation of pancreatic ductal adenocarcinoma (PDAC) could be associated with prognosis and may influence the choices of clinical management. No applicable methods could reliably predict the tumor differentiation preoperatively. Thus, the aim of this study was to compare the metabonomic profiling o...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3703-9

    authors: Wen S,Zhan B,Feng J,Hu W,Lin X,Bai J,Huang H

    更新日期:2017-11-02 00:00:00

  • Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer.

    abstract:BACKGROUND:Genome wide association studies (GWAS) have identified several genetic variants that are associated with prostate cancer. Most of these variants, like other GWAS association signals, are located in non-coding regions of potential candidate genes, and thus could act at the level of the mRNA transcript. METHO...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-315

    authors: Harries LW,Perry JR,McCullagh P,Crundwell M

    更新日期:2010-06-22 00:00:00

  • Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer.

    abstract:BACKGROUND:The neutrophil-to-lymphocyte ratio (NLR), a simple marker of the systemic inflammatory response in critical care patients, has been suggested as an independent prognostic factor for several solid malignancies. We investigated the utility of pretreatment NLR as a prognosticator in patients who presented with ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2134-3

    authors: Kawahara T,Yokomizo Y,Ito Y,Ito H,Ishiguro H,Teranishi J,Makiyama K,Miyoshi Y,Miyamoto H,Yao M,Uemura H

    更新日期:2016-02-16 00:00:00

  • Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2-negative metastatic breast cancer: a network meta-analysis.

    abstract:BACKGROUND:It is not known what combination of bevacizumab and chemotherapy agents is the best therapeutic regimen. Comparative study results among the efficacies of bevacizumab plus chemotherapy remain controversial in patients with HER2-negative metastatic breast cancer. METHODS:We searched Pubmed, Embase, and Cochr...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-020-6674-1

    authors: Sun Z,Lan X,Xu S,Li S,Xi Y

    更新日期:2020-03-04 00:00:00

  • Expression profile and prognostic role of sex hormone receptors in gastric cancer.

    abstract:BACKGROUND:Increasing interest has been devoted to the expression and possible role of sex hormone receptors in gastric cancer, but most of these findings are controversial. In the present study, the expression profile of sex hormone receptors in gastric cancer and their clinicopathological and prognostic value were de...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-566

    authors: Gan L,He J,Zhang X,Zhang YJ,Yu GZ,Chen Y,Pan J,Wang JJ,Wang X

    更新日期:2012-12-02 00:00:00

  • Intraneural metastasis of gastric carcinoma leads to sciatic nerve palsy.

    abstract:BACKGROUND:Soft tissue metastases, in particular intraneural metastasis, from any carcinomas seldom occur. To our knowledge, no case of sciatic nerve palsy due to intraneural metastasis of gastric carcinoma is reported in the literature. CASE PRESENTATION:A case is reported of a 82-year old woman with sciatic nerve pa...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-313

    authors: Ichikawa J,Matsumoto S,Shimoji T,Tanizawa T,Gokita T,Hayakawa K,Aoki K,Ina S,Kanda H

    更新日期:2012-07-25 00:00:00

  • Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis.

    abstract:BACKGROUND:Pancreatic ductal adenocarcinoma (PDAC) is considered as one of the most aggressive cancers lacking efficient early detection biomarkers. Circulating miRNAs are now being considered to have potency to be used as diagnostic and prognostic biomarkers in different diseases as well as cancers. In case of cancer,...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-019-6380-z

    authors: Chhatriya B,Mukherjee M,Ray S,Sarkar P,Chatterjee S,Nath D,Das K,Goswami S

    更新日期:2019-12-03 00:00:00

  • A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma.

    abstract:BACKGROUND:The aim of this study was to examine the efficacy and safety of everolimus in patients with progressive unresectable adenoid cystic carcinoma (ACC). METHODS:Histologically confirmed ACC patients with documented disease progression within 12 months prior to the study entry were eligible. Everolimus was given...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/1471-2407-14-795

    authors: Kim DW,Oh DY,Shin SH,Kang JH,Cho BC,Chung JS,Kim H,Park KU,Kwon JH,Han JY,Kim MJ,Bang YJ

    更新日期:2014-11-03 00:00:00

  • Relevance of internal time and circadian robustness for cancer patients.

    abstract:BACKGROUND:Adequate circadian timing of cancer treatment schedules (chronotherapy) can enhance tolerance and efficacy several-fold in experimental and clinical situations. However, the optimal timing varies according to sex, genetic background and lifestyle. Here, we compute the individual phase of the Circadian Timing...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2319-9

    authors: Ortiz-Tudela E,Innominato PF,Rol MA,Lévi F,Madrid JA

    更新日期:2016-04-21 00:00:00

  • Mutational landscape differences between young-onset and older-onset breast cancer patients.

    abstract:BACKGROUND:The incidence of breast cancer among young women (aged ≤40 years) has increased in North America and Europe. Fewer than 10% of cases among young women are attributable to inherited BRCA1 or BRCA2 mutations, suggesting an important role for somatic mutations. This study investigated genomic differences betwee...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6684-z

    authors: Mealey NE,O'Sullivan DE,Pader J,Ruan Y,Wang E,Quan ML,Brenner DR

    更新日期:2020-03-12 00:00:00